A detailed history of Scotia Capital Inc. transactions in Danaher Corp stock. As of the latest transaction made, Scotia Capital Inc. holds 326,493 shares of DHR stock, worth $78.2 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
326,493
Previous 312,751 4.39%
Holding current value
$78.2 Million
Previous $78.1 Million 16.15%
% of portfolio
0.51%
Previous 0.46%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$239.25 - $280.76 $3.29 Million - $3.86 Million
13,742 Added 4.39%
326,493 $90.8 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $4.99 Million - $5.67 Million
21,172 Added 7.26%
312,751 $78.1 Million
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $11 Million - $12.5 Million
48,772 Added 20.09%
291,579 $72.8 Million
Q4 2023

Feb 12, 2024

SELL
$185.1 - $233.13 $3.92 Million - $4.94 Million
-21,169 Reduced 8.02%
242,807 $56.2 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $11.7 Million - $13.3 Million
50,008 Added 23.37%
263,976 $65.5 Million
Q2 2023

Aug 03, 2023

BUY
$224.99 - $256.14 $6.22 Million - $7.09 Million
27,667 Added 14.85%
213,968 $51.4 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $807,238 - $932,659
3,367 Added 1.84%
186,301 $47 Million
Q4 2022

Feb 09, 2023

BUY
$241.42 - $282.29 $881,907 - $1.03 Million
3,653 Added 2.04%
182,934 $48.6 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $1.2 Million - $7.32 Million
4,857 Added 2.78%
179,281 $46.3 Million
Q2 2022

Aug 05, 2022

BUY
$237.11 - $299.66 $1.6 Million - $2.02 Million
6,740 Added 4.02%
174,424 $44.2 Million
Q1 2022

May 09, 2022

SELL
$257.27 - $315.76 $577,056 - $708,249
-2,243 Reduced 1.32%
167,684 $49.2 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $2.54 Million - $2.86 Million
8,693 Added 5.39%
169,927 $55.9 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $4.07 Million - $4.96 Million
14,935 Added 10.21%
161,234 $49.1 Million
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $4.08 Million - $4.93 Million
18,131 Added 14.15%
146,299 $39.3 Million
Q1 2021

May 06, 2021

BUY
$212.38 - $245.9 $500,154 - $579,094
2,355 Added 1.87%
128,168 $28.8 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $2.54 Million - $2.93 Million
-11,943 Reduced 8.67%
125,813 $27.9 Million
Q3 2020

Nov 12, 2020

BUY
$177.16 - $215.33 $469,474 - $570,624
2,650 Added 1.96%
137,756 $29.7 Million
Q2 2020

Aug 11, 2020

BUY
$128.7 - $176.83 $41,698 - $57,292
324 Added 0.24%
135,106 $23.9 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $1.03 Million - $1.43 Million
-8,447 Reduced 5.9%
134,782 $18.7 Million
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $2.46 Million - $2.83 Million
18,420 Added 14.76%
143,229 $22 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $2.67 Million - $2.89 Million
19,750 Added 18.8%
124,809 $18 Million
Q2 2019

Aug 13, 2019

BUY
$124.88 - $143.73 $3.36 Million - $3.87 Million
26,935 Added 34.48%
105,059 $15 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $1.08 Million - $1.47 Million
11,092 Added 16.55%
78,124 $10.3 Million
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $629,519 - $727,016
6,637 Added 10.99%
67,032 $6.91 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $380,057 - $421,769
3,873 Added 6.85%
60,395 $6.56 Million
Q2 2018

Aug 13, 2018

BUY
$96.1 - $103.24 $55,641 - $59,775
579 Added 1.03%
56,522 $5.51 Million
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $1.08 Million - $1.21 Million
11,665 Added 26.34%
55,943 $5.48 Million
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $1.13 Million - $1.25 Million
13,245 Added 42.68%
44,278 $4.11 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $1.21 Million - $1.35 Million
15,302 Added 97.27%
31,033 $2.66 Million
Q2 2017

Aug 15, 2017

BUY
N/A
15,731
15,731 $1.33 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.